synthetic impurities, thereby allowing a thorough cleanup and substantial reduction of sample complexity for MS analyses.
The procedure also includes the preparation of CPG-hydrazide, which is a synthetic intermediate (Fig. 2c) ; as this has not yet been fully described, references have usually been made to a publication that gave only a brief description on its synthesis 22 .
Development of the protocol
The SPAER approach was inspired by our previous studies successfully enriching for MS analyses protein carbonyls via chemoprecipitation 23, 24 . By using a solid-phase hydrazide reagent assembled on commercially available CPG-C 3 H 7 -NH 2 beads ('CPG-hydrazide' shown in Fig. 2c ), carbonylated peptides are immobilized and the interfering 'matrix' of unmodified peptides remaining in solution can be removed successfully. The technique is essentially the same practice that has been used in solid-phase peptide synthesis (SPPS) pioneered by Merrifield 25 , in which the peptide chain is elongated on a solid support while all soluble reagents are removed by simple washing. Purification is simplified to washing-filtration cycles only and, once the desired peptide chain has been assembled, the covalently attached product can be cleaved from the solid support. For peptide carbonyl enrichment, immobilization involves hydrazide chemistry, and thus the original peptide carbonyls can be released by acid-catalyzed hydrolysis for MS analyses [22] [23] [24] .
We have recognized that anchoring a small-molecule formylsubstituted carboxylic acid or preferably its active ester, via its carbonyl group to CPG-hydrazide ( Fig. 2d) , would result in a simple solid-phase reagent (i.e., SPAER) that would be capable of selectively capturing nitropeptides from an overwhelming matrix of non-nitrated species according to a procedure summarized schematically in Figure 3 . To do that, similarly to enrichment methods developed by others and discussed before 21 , we had to convert 3NTs to the corresponding aminotyrosines (3ATs) ( Fig. 3a; ref. 26 ). Reduction of −NO 2 to −NH 2 is the most trivial choice to create a convenient synthetic handle for covalent immobilization of nitropeptides on a solid support. This modification is necessary, because only a limited number of chemical reactions are known in organic chemistry that are suitable to manipulate the NO 2 group without requiring special skills and vigorous reaction conditions.
To single out amino groups on 3ATs from those at the N termini and lysine (Lys, K) side chains, the latter amino groups must be protected (capped) before reduction of 3NTs to 3ATs takes place. This has been mostly achieved by N-acetylation 27 , because it has been a well-established protocol in SPPS 28 . However, besides losing potentially useful ionization sites for MS analyses that affect sensitivity, removal of the O-acyl side products requires treatment with a large quantity of an additional reagent or harsh reaction conditions 21 . We therefore chose to use reductive methylation 29, 30 (Fig. 3a) to block all native −NH 2 groups of the proteolytic peptides before 3NT-to-3AT conversion. The usefulness of this straightforward reaction to label peptides for quantitative MS experiments has been convincingly shown 30 . Our protocol takes advantage of two established and validated synthetic steps (Fig. 3a) before the covalent capture of the modified peptides by SPAER ( Fig. 3b ; ref. 21) . 
SPAER development.
We selected a commercially available active ester, 4-formylbenzoic acid N-hydroxysuccinimide ester (4FB-OSu), for the reaction with CPG-hydrazide to create SPAER (Fig. 2d) . Although we used N-hydroxysuccinimide ester (−OSu) from a practical point of view (i.e., commercial availability), we believe that other active esters (e.g., 1-hydroxybenzotriazole active ester traditionally used in SPPS) would also be suitable 28 , even when they are generated in situ (see Steps 9 and 10 in the PROCEDURE). After thorough washing, the captured species can be released from the glass beads via an acid-catalyzed hydrolysis at ambient temperature by using a short reaction period. The released peptides will have two modifications: dimethylation on the native aliphatic amino groups and a small tag (i.e., 4-formylbenzamido) on the Tyr residues, as shown in Figure 3c .
This tag seems to have three major advantages 21 : (i) it preserves the fragmentation properties of the parent nitropeptides upon MS/MS analyses by using collisioninduced dissociation (CID); (ii) it eliminates the electron predator effect of −NO 2 groups allowing complimentary ionization methods such as electron-capture dissociation to improve sequence coverage; (iii) the tagged species now carry 4-formylbenzamido groups instead of the original nitro groups and, therefore, they can be further enriched as peptide carbonyls by using the CPG-hydrazide reagent ( Fig. 2; refs. [22] [23] [24] if further ('tandem') enrichment is deemed necessary after reviewing the results of the SPAER-only protocol.
Applications of the method
The protocol described here enables the specific capture of nitropeptides from proteolytic digests of complex proteomes followed by the release of tagged species for mass-spectrometric analyses 21 . The method has been applied in a qualitative 'shotgun' design using data-dependent LC-MS/MS for the identification of protein targets of post-translational Tyr nitration including precise identification of the modification sites 21 . With their improved detection sensitivity and increased speed of acquisition, newer mass spectrometers should permit applications not only to test tube or cell culture experiments but also to tissue-derived samples in studies focused on this important PTM as a signaling event 3, 31 or as a biomarker of nitroxidative stress 2,32 affecting a specific subset of proteins in the proteome-and also localized to specific Tyr residues within these targeted proteins.
Quantitative measurements comparing the relative extent of site-specific protein Tyr nitration by the SPAER-based enrichment method can be achieved through stable-isotope dimethyl labeling 30, 33 , because the corresponding reductive alkylation is our method of choice to block all native amino groups before the reduction of 3NTs to 3ATs (Fig. 3a) . Multiplex peptide stableisotope dimethyl labeling has been an established method, and users interested in implementing it are referred to its published protocol 30 . In contrast, there would be no restriction to using our enrichment procedure in combination with other labeling techniques used in MS-based quantitative proteomics such as stable-isotope labeling with amino acids in cell culture (SILAC) 34 or its in vivo adaptation 35 . Selected reaction monitoring (SRM) using labeled ('heavy') synthetic nitropeptides as internal standards 36, 37 , in combination with the chemoprecipitation protocol described here, also has the potential to afford quantification of the nitroproteome including localization of these PTMs. S u p e r n a t a n t S u p e r n a t a n t In addition, data-independent acquisitions using sequential windowed data-independent acquisition of the total high-resolution (SWATH)-MS measurements and isotopically labeled heavy peptides 38 may be an alternative proteomics approach for integrating targeted quantifications of protein Tyr nitration when combined with the SPAER-based enrichment.
Comparison with other methods
Although biochemists and biologists may have a preference to adopt immunoaffinity-based methods that apply immobilized antibodies for the enrichment of nitropeptides, cross-reactivities have been revealed even with the use of custom-made monoclonal anti-3NT and thorough characterization of affinities and binding specificities 39 . Therefore, the advantage of adhering to a routine practice is outweighed by the procedure's poor efficiency, lack of selectivity and overall unreliability for discovery-driven nitroproteomics. After pre-enrichment by immunoprecipitation with anti-3NT antibodies, attachment of a tag such as biotin after chemical derivatizations has been developed for the enrichment on an immunoaffinity column with immobilized antibodies (streptavidin) recognizing the introduced affinity tag in proteolytic peptides 40 . Apart from the need for multiple steps in the procedure, naturally biotinylated peptides would also be enriched. This would contaminate the sample and, therefore, could interfere with the identification of low-abundance nitropeptides. Chemical modifications have been introduced into methods via the attachment of a fluorophore tag after reduction of 3NT residues 41, 42 . These procedures would permit the detection of the tagged peptides and proteins by spectrofluorimetry and western blotting, respectively. During online HPLC separation, elution of a tagged (e.g., dansylated) nitropeptide is detected fluorimetrically, which is then used to trigger MS/MS data acquisition to enable peptide identification 41 . Isobaric tags for relative and absolute quantification (iTRAQ) also have been applied to bottom-up exploration of the nitroproteome 43 . Application of the fluorophore-based and iTRAQ methods without the enrichment of the tagged nitropeptides could raise concerns about suppression effects and undersampling due to the presence of a potentially overwhelming matrix. Additional instrumentation and technical expertise are also necessary to adapt these methods for MS-based nitroproteomics. Therefore, a very simple chemoprecipitation approach would be clearly advantageous. This also applies to diagonal chromatography that distinguishes nitropeptides from nonnitro species on the basis of retention time shifts after the usual sodium dithionite reduction 26 in narrow fractions from offline reversed-phase liquid chromatography (RPLC) of the sample 44 .
Other methods also take advantage of the unique chemical properties and reactivity of the nitro group to facilitate efficient and selective enrichment of nitropeptides. Specifically, the reduction of 3NTs to the corresponding 3ATs (ref. 26 ) is used in combination with other chemical derivatization(s) to ensure selectivity. However, there have been several varieties of the procedures in terms of materials, reagents and, importantly, in the number of reaction steps. The SPAER approach uses only two steps of simple and routine derivatization reactions before covalent immobilization, whereas similar methods use multistep chemical conversions 27, 45 to introduce a metal-chelating motif for noncovalent immobilization 46 , which discourages their implementation by the laboratories of nonspecialists. Reductive dimethylation furnishes several benefits 21, 33 (essentially quantitative conversion, no hydrophobic shift in RPLC retention, preservation of MS sensitivity with the tagged peptides, commercial availability of the reagent in multiple stable isotopelabeled forms, etc.) over acetylation as capping chemistry 27, 45, 46 . In addition, the use of CPG beads in our protocol allows for a more thorough washing to remove non-nitro peptides 33 , because alternative methodologies 27, 45, 46 use a polymer (agarose) support that is not as resistant to organic solvents as CPG.
Experimental design
To identify protein targets for post-translational Tyr nitration with localization of modification sites through discovery-driven proteomics, a qualitative approach is sufficient, and we recommend two independent enrichment experiments when enough sample is available. A typical workflow is done by following Steps 19-47 of the protocol by using light formaldehyde and sodium cyanoborohydride solutions as dimethylation reagents A and B (Reagent Setup). A control experiment is one in which
Step 27 of the protocol is done without the addition of sodium dithionite, from which no valid nitropeptide identifications should be made. Capture of incompletely dimethylated peptides, if any, could alert users about the need for optimization of the protocol to their samples and about the possibility of misidentifications when using protein database searches with relaxed criteria upon actual data analysis. Manual validation should be a vital component of the proper spectral assignments 19, 47 , and Box 1 summarizes the procedure we recommend. Human serum albumin nitrated with tetranitromethane with confirmed presence of several nitropeptides can be used as a positive control sample 48 .
Additional validation beyond MS/MS spectra may be warranted for endogenous 3NT-containing peptides detected from tissue samples 47 . If doubts remain after manual validation (Box 1) or if further confirmation is to be pursued 47 , consider custom synthesis of the nitropeptide 19 and complete the protocol from Steps 21 to 47 by using a 15 µg/ml solution of the synthetic nitropeptide in triethylammonium bicarbonate buffer as a reference sample. The MS/MS spectrum from the raw data file of the dimethylated and tagged synthetic peptide should match with the MS/MS spectrum obtained on the putative nitropeptide enriched and analyzed from the biological sample.
Quantitative design relying on multiplex peptide stable-isotope dimethyl labeling should follow its published protocol 30 . We recommend the use of D 13 CDO and sodium cyanoborohydride as reagents to perform heavy dimethyl labeling in two-way differential quantification experiments 33 , whereas three-way multiplexing should use DCDO and sodium cyanoborohydride for intermediate labeling and D 13 CDO and sodium cyanoborodeuteride for heavy labeling to avoid signal interference ('cross-talk') among the labeled forms of the peptides 49 . A Java program is available for the deconvolution of overlapping isotopic clusters (https:// trac.nbic.nl/opf/), if required. Rigorous quantitative designs also should consider a pseudo triplex approach even for a two-way comparison (in this design, two identical samples are labeled with light and heavy reagents, respectively, while another comparative sample is labeled with intermediate forms) 50 .
Limitations
Although reductive dimethylation has been proven to be essentially quantitative with no side reactions in proteomics workflows, including our nitropeptide chemoprecipitation approach 21 , O-sulfation has been shown for dithionite reduction of 3NTs to 3ATs (ref. 44 ) to yield by-products. We estimate that the percentage of nitropeptides that results in a predominant formation of O-sulfated 3AT peptides may reach ~10%. In principle, these byproducts can also be enriched by our SPAER-based chemoprecipitation. Protein database searches can be carried out by including Tyr O-sulfation as an additional variable modification, which will reveal the extent of by-product formation through the percentage of O-sulfated nitropeptides within the total nitropeptide identifications obtained. However, including Tyr O-sulfation as variable modification could increase false discovery rate (FDR) among the identified hits owing to the added 'degree of freedom' (we also note that estimation of FDR in large-scale proteomics studies focused on PTMs may be inherently difficult 51 ). The enrichment of nitrotryptophan-containing peptides by using SPAER can also be presumed 52 . However, the chemistry of dithionite reduction has not been fully tested for the isomeric forms of these nitropeptides.
Box 1 | Manual validation of MS/MS-based peptide identifications
We recommend the use of MS-Product tool of ProteinProspector (available at http://prospector.ucsf.edu/prospector/cgi-bin/msform. cgi?form=msproduct) to annotate the CID-MS/MS spectra of dimethylated and tagged 3AT peptides. Enter 'Dimethyl' in the n term box of the web form, and type the sequence from a search hit into the sequence box by using one-letter abbreviations for the amino acid residues. Include the mass of the tag (147.032) and side chain modifications by appropriate names in parentheses (click the [±] sign above the entry boxes to see the available modifications, and enter them exactly as shown in the list). For example, the sequence of # DY ∆ FMPC @ PGR identified in Figure 5b should be entered as DY(147.032)FMPC(Carbamidomethyl)PGR. Should the tryptic peptide contain carboxy-terminal lysine (K), type '(Dimethyl)' after K in the sequence entry box. Leave the c term box empty. Check the box after the use instrument-specific defaults to override ion types item, and set Max charge under the 'Induce Fragmentation' button to the charge of the precursor, if known, and enter 3 if unknown. Select the appropriate type of mass spectrometer from the Instrument menu below and then click the 'Induce Fragmentation' button. Fragments are summarized in the Main Sequence Ions, All Sequence Ions and Theoretical Peak Table items. Click the [±] sign before the theoretical peak table and match the list to the m/z of the fragments observed in the MS/MS spectrum queried (within product-ion mass accuracy of the instrument used). You may consider the peptide identification valid if it meets the following criteria 19 : 1. The modified peptide has more than seven amino acid residues in the sequence. 2. Theoretical precursor m/z is within the mass accuracy attainable by the instrument. 3. MS/MS peaks with >20% relative abundance and six of top ten peaks are annotated. 4. The dimethyl-labeled non-nitrated peptide is identified from the first flow-through (supernatant) of Step 30. 5. The annotated MS/MS peaks conform to rules of peptide fragmentation by using CID.
Although no rules have been established for the fragmentation of dimethylated and tagged 3AT-containing peptide sequences, several can be adapted from those applied to automated expert validation of phosphopeptide MS/MS-spectrum matches (ProPhosSI) 55 :
• Four sequential b-or y-ions are observed.
• Five of six sequential ions are present.
• Distinctive fragmentation patterns around Pro, if found in the sequence, are observed (if there is no Pro, this test automatically passes). This rule recognizes that cleaving the imino bond N-terminal to the residue should be one of the major peaks in the CID-MS/MS spectrum, whereas fragmentation of the C-terminal amino bond of Pro should be very weak. With more than one Pro in the sequence, this criterion is met if at least one of the Pro residues has the expected fragment-intensity distribution.
• Tag-specific mass differences between the series of ions on either side of the modified Tyr are confirmed (which reflects that the tag is presumed not labile under low-energy CID conditions. Note that high-energy CID has not been tested.
The CID-MS/MS spectrum of # DY ∆ FMPC @ PGR (from the doubly protonated precursor, m/z 659.2767) shown in Figure 5 is an excellent example of meeting all criteria above.
MaterIals

REAGENTS
! cautIon Most reagents used in the protocol are toxic and harmful by inhalation, on contact with skin or if swallowed. Piperidine also has an extremely unpleasant odor. Organic solvents are also flammable. TFA and acetic acid are corrosive. Ammonia solution is an irritant. Therefore, all solvents and chemicals should be handled in an efficient chemical fume hood and by wearing appropriate personal protective equipment (gloves, lab coat, protective eye glasses and mask). The chemical procedures also must be performed in an efficient fume hood.
Acetic 
EQUIPMENT SETUP LC-MS/MS equipment
In our setup, a 15 cm × 75 µm inner diameter PepMap C18 nanoflow column is installed in the Nano-LC-2D system. The peptide solution (5 µl) is loaded onto a 2.5 cm × 75 µm sample trap for desalting and concentrating the sample at a flow rate of 1.5 µl/min in the HPLC loading solvent. Separation is performed at a constant flow rate of 250 nl/min after a 5-min equilibration with 4.8% solvent B, followed by a 90-min gradient to 50% solvent B. Solvent B is held at 50% for 5 min and then increased to 90% in 5 min with return to 4.8% solvent B in 10 min. Full-scan Fourier transform MS mass spectra are acquired from m/z 350-1,500 at a mass resolution of 50,000 and with an automated gain control (AGC) value of 1 × 10 6 ; data-dependent acquisition is performed with an automated gain control value of 3 × 10 4 and the five most intense parent ions selected for MS/MS analysis in the linear ion trap by using CID with 35% normalized collision energy and helium as the collision gas 21, 33 . Singly charged precursors and precursors with unassigned charges are excluded, and dynamic exclusion from further MS/MS analysis is applied for 60 s. (Fig. 2a) .
2|
Weigh 500 mg of CPG-C 3 H 7 -NH 2 into a 20-ml LibraTube fitted with a two-way stop valve (reaction vessel).
3| Add 5 ml of DMF with an automatic pipette and gently shake the tube for 2 min on a tube shaker/rotator to wet the beads.  crItIcal step Instead of DMF, N-methyl-2-pyrrolidinone (Sigma-Aldrich, cat. no. 69116) can also be a solvent of choice. The latter solvent is frequently used in Fmoc-based SPPS, and it shows enhanced chemical stability compared with that of DMF.
4|
Open the valve to drain the solvent as you would carry out a regular vacuum filtration.
For example, a vacuum manifold (e.g., Vac-Man laboratory vacuum manifold from Promega, cat no. A7231) can be used for holding the reaction vessel upon draining the solvents/reaction medium. In this case, place the vacuum manifold in a fume hood and connect it to vacuum through a trap. Place LibraTube G20 containing the glass beads onto the vacuum manifold, and cap all unused inlets with rubber septa.
5|
Close the valve and add 5 ml of DMF, followed by 500 mg (5 mmol) of SA and 200 µl of DIPEA (4% (vol/vol)).
6|
Shake the reaction vessel for 3 h by using the tube shaker/rotator or similar equipment, and then open the valve to drain the reaction medium with vacuum filtration.
7|
Wash the beads and the reaction vessel thoroughly three times with DMF (3 × 5 ml) followed by DCM (3 × 5 ml) while applying vacuum to remove any residual reaction medium.
8|
Dry the beads by applying vacuum until the solvent evaporates. The succinylated beads are now ready for hydrazide beads (CPG-hydrazide) preparation.
preparation of cpG-hydrazide • tIMInG ~7 h 9| Calculate the amount of reagents (HOSu, DIC and Fmoc-NH-NH 2 ) needed that represents a tenfold molar excess over the loading. The values in the steps that follow correspond to the calculation done in Step 1 (Fig. 2b,c) .
10| Add 5 ml of DMF with an automatic pipette to the succinylated beads, and then add 115 mg (1 mmol) of HOSu, 254 mg (1 mmol) of Fmoc-NH-NH 2 and 175 µl (1 mmol) of DIC. Shake the reaction vessel for 3 h in the Labquake tube shaker/rotator or similar equipment.  crItIcal step With Step 10, we activate the carboxylic groups on the succinylated beads in situ by using HOSu and DIC to generate -OSu active esters; however, other reagents such as the widely used 1-hydroxybenzotriazole (HOBt) 28 are also suitable for this purpose.
11|
Open the valve to remove the reaction medium by vacuum filtration, and then wash the beads and the reaction vessel thoroughly from the top by using DMF (3 × 5 ml), methanol (3 × 5 ml) and DCM (3 × 5 ml) while applying vacuum.
12|
Remove the Fmoc-protecting group by adding 4 ml of DMF to the beads, followed by 1 ml of piperidine (i.e., 20% (vol/vol) piperidine in DMF). Shake the reaction vessel by using a Labquake tube shaker/rotator or similar equipment for 20 min.
13|
Open the valve to remove the reaction medium, and thoroughly wash the beads and the reaction vessel with DMF (3 × 5 ml), methanol (3 × 5 ml), and finally with DCM (3 × 5 ml).  crItIcal step At this point, you may save an aliquot of the CPG-hydrazide beads if you are also interested in the enrichment of peptide carbonyls based on chemoprecipitation [22] [23] [24] . In Step 15, leading to SPAER, the amount of reagent is calculated for the entire starting quantity of CPG-C 3 H 7 -NH 2 beads (0.5 g). Modify the amount of reagent according to the amount of CPG-hydrazide beads used for SPAER preparation considering tenfold molar excess of 4FB-OSu over the original (0.2 mmol/g) loading.  pause poInt At this point, you may store the dried beads at −20 °C under nitrogen for extended period of time.
condensation of cpG-hydrazide with 4FB-osu • tIMInG ~8 h 14| Wet CPG-hydrazide with 5 ml of ACN/H 2 O (7:3 (vol/vol)) (Fig. 2d) .
15|
Drain the solvent and then treat the beads with 247 mg (1 mmol) of 4FB-OSu in 5 ml of ACN/H 2 O (7:3 (vol/vol)) containing 0.2% (vol/vol) acetic acid.
16| Shake the reaction mixture for ~6 h on the Labquake tube shaker/rotator or similar equipment.
17|
Open the valve to drain the reaction medium, and wash the beads and the reaction vessel thoroughly first with ACN/H 2 O (7:3 (vol/vol)) (3 × 5 ml) and then with H 2 O (3 × 5 ml), followed by ACN (3 × 5 ml) and finally with DCM (3 × 5 ml).
18| Dry the SPAER under vacuum and store the beads under nitrogen at −20 °C.  crItIcal step When the SPAER protocol for the enrichment of nitropeptides is performed for the first time, it is advisable to evaluate SPAER and to become familiar with the technique by 'fishing out' a known quantity of a limited number of purified synthetic nitropeptides according to Steps 21-47 below. Custom-synthesized peptides with 3NT residues can be ordered from commercial vendors (e.g., Synthetic Biomolecules) by specifying the sequences and required purity (>95% preferred). Combustion analyses (performed by, e.g., Atlantic Microlab) will be necessary to calculate the exact peptide contents. Alternatively, nitration of the universal proteomics standard set USP1 by tetranitromethane could be used as a quality control of the protocol, from enrichment to data analysis 47 , considering the user's MS platform and the detailed supporting information of the cited reference. ? trouBlesHootInG part 2, sample preparation and spaer enrichment: proteolytic digestion of protein samples • tIMInG ~1 d  crItIcal All procedures are done at room temperature (20-25 °C) , unless otherwise noted. 19| Determine the protein content of the sample by the Bradford assay 53 , and perform trypsin or Lys-C/trypsin combination digestion according to previously published procedures 54 .
20| Dry the sample in a SpeedVac in a 1.5-ml Eppendorf centrifuge tube.  pause poInt At this point, the dried samples can be stored at −20 °C for several weeks.
pre-enrichment derivatizations • tIMInG ~2 d  crItIcal Cap the N-terminal and side chain native amino groups of the proteolytic peptides via reductive methylation according to the previously published protocol 30 . Use only formaldehyde if no differential labeling is desired. For multiplex stable-isotope labeling, you may use not only formaldehyde and sodium cyanoborohydride but also DCDO and/or D 13 CDO, as well as sodium cyanoborodeuteride 30, 33 (see Reagent Setup section for dimethylation solutions A and B). In addition, instead of triethylammonium bicarbonate (Sigma-Aldrich, cat. no. T7408), sodium acetate buffer (see 'Dimethylation solution' under Reagent Setup) can also be used.
21| Reconstitute the digested samples from
Step 20 in 100 µl of 100 mM triethylammonium bicarbonate (Fig. 3a) .  crItIcal step Do not use any buffer or other reagents with free aliphatic amino groups, as they will also be participating in the reductive dimethylation process. 25| Add 8 µl of FA to further quench the reaction and to acidify the sample for the subsequent SPE. ? trouBlesHootInG 26| Clean up the dimethylated samples with SPE by using C18 Sep-Pak cartridge according to the manufacturer's instruction. Condition the column with 3 × 1 ml of ACN and 3 × 1 ml of SPE loading solution. Load the samples to the column. Wash the samples with 4 column volumes of SPE washing solution. Elute the peptides with 1 ml of SPE elution solution. Dry the samples by using SpeedVac in a 1.5-ml Eppendorf centrifuge tube.  crItIcal step Different volumes of conditioning or washing solutions may be applied on the basis of the size of C18 cartridge used in the experiments. Select the correct size of the cartridge according to the manufacturer's recommendation.  pause poInt Store the dried samples at −20 °C until further use.
27|
Reconstitute the dimethylated sample in 300 µl of 100 mM phosphate buffer (pH 7.5) in a 1.5-ml Eppendorf centrifuge tube, and add ~500-fold molar excess of sodium dithionite (in a 300-µl aqueous solution) over the protein content determined in Step 19. Adjust the pH to about 8 by adding 5% (wt/vol) aqueous NaOH solution. Rotate the mixture for 30 min on the Labquake tube shaker/rotator or similar equipment. ? trouBlesHootInG 28| Quench the reaction by acidifying the solution with 50% (vol/vol) acetic acid to pH 3 while incubating the reaction mixture for 30 min.
chemoprecipitation by spaer and subsequent release of the tagged species • tIMInG ~1 d 29| Increase the pH of the solution from pH 3 to ~5.5 with aqueous NaOH (5% wt/vol) solution (Fig. 3b,c) .  crItIcal step A pH of ~5 is optimal for the reaction between 3ATs and the immobilized 4FB-Osu, which is stable at this pH.
30|
Measure out ~10 mg of SPAER (representing ~0.2 mmol/g loading) directly into a screw-cap spin column equipped with the larger frit at the bottom of the column. Make sure that the column plug for the spin column is in place. Figure 4 summarizes schematically the capture and release procedure described below.  crItIcal step Follow the manufacturer's instructions to assemble the spin column set.
31|
Transfer the reaction mixture with an automatic pipette from Step 29 (i.e., from the of the dimethylated 3AT-containing peptides) into the spin column containing SPAER. Close the spin column with the screw cap.
32|
Rotate the resultant slurry for 6−8 h by using the Labquake tube shaker/rotator or similar equipment.
33|
Remove the column plug and place the spin column into a 1.5-ml Eppendorf centrifuge tube and pellet the SPAER by centrifugation at 1,500g for 90 s to collect the supernatant as the flow-through.  crItIcal step Analyze the flow-through by LC-MS/MS. If the results reveal the presence of 3AT-containing peptides, perform a secondary enrichment (i.e., repeat Steps 29-32 above). In this case, use a 4-6-h reaction time and, after pelleting the SPAER, combine the SPAER beads from the primary and secondary enrichments.
34|
Replace the screw cap with a Luer-Lok and remove the column plug. To elute nonbinding peptides and other synthetic impurities, thoroughly wash the beads and the spin column by slowly pushing through the washing solution while gently applying vacuum (optional). Use the following solvents in the given order: 8 M freshly made urea in PBS; 2 M NaCl; 80% (vol/vol) ACN/H 2 O containing 0.1% (vol/vol) acetic acid; ACN; DMF; DCM; methanol; and, finally, H 2 O. For each washing solvent, use 4 × 5 ml.  crItIcal step By slowly pushing the washing solvent through the beads, make sure to gently generate a slurry of the beads to thoroughly clean them.
35|
Replace the screw cap or close the Luer-Lok adapter and dry the beads by placing the spin column on a stand connected to vacuum.  pause poInt At this point, the SPAER containing the immobilized 3AT-containing peptides can be stored under nitrogen at −20 °C for up to 1 week.
36|
Carefully transfer the dried SPAER into a 1.5-ml Eppendorf centrifuge tube.
37|
Treat the beads with 300 µl of 95% (vol/vol) TFA/H 2 O to facilitate the release of the captured peptides of interest.
38| Rotate the resultant slurry by using the Labquake tube shaker/rotator or similar for 30 min.
39|
Pellet the beads at 1,500g for 90 s and collect the supernatant. 41| Combine the collected supernatants and evaporate the solvent under a gentle nitrogen stream to almost dry. ! cautIon TFA is corrosive; proceed with extra caution and use a fume hood. Also handle the flow-through carefully, because it contains the tagged peptides of interest.  crItIcal step Evaporation of the sample to complete dryness may lead to sample loss.  crItIcal step Although direct treatment of the beads with the acidic medium directly in the spin column (Step 37) to release of the tagged peptides is possible, we found strong polymer contamination (probably originating from the frit material) upon LC-MS/MS analysis.  pause poInt The sample can be stored at −20 °C until LC-MS/MS analysis. 
lc-Ms/Ms
• tIMInG variable (dependent on the number of samples) 48| Run the samples according to the complexity and sensitivity of the enriched peptides. We recommend a longer gradient (e.g., 90-120 min for 0−50% HPLC mobile phase B) after enrichment from complex samples (e.g., nonfractionated human plasma digest), or a short gradient (45 min) after enrichment from less complex samples (e.g., digest of a single nitrated protein).
Data analysis • tIMInG variable (dependent on the number of raw data files) 49|
Explore the LC-MS spectra by using the Xcalibur's Qual Browser program to check the quality of data. Extract peak lists with Bioworks (version 3.3, Thermo) for database search.
50|
Use search engines such as Mascot (Matrix Science), Sequest (Thermo), X!Tandem or equivalent, to identify peptides by searching the NCBI or UniProt protein sequence database for the species of interest. Apply the following settings and options when performing the searches: specify trypsin as the digesting enzyme with one missed cleavage allowed.
51| Set parent-ion and fragment-ion mass tolerances to 25 p.p.m. and 0.80 Da, respectively, when using a linear ion trap-FTMS hybrid instrument with MS/MS performed in the linear ion trap (adjust these tolerances according to precursorand product-ion mass accuracy attainable with the instrument and chosen MS/MS method). 
52|
antIcIpateD results
The protocol using SPAER-based chemoprecipitation is expected to remove or markedly diminish overwhelming amounts of non-nitrated species from complex biological samples, which would enable in-depth mass-spectrometric analyses and the exploration of the nitroproteome. Hundreds of nitroproteins and modification sites could be identified by using today's mass spectrometers after in vitro protein nitration. The example summarized in Figure 5 shows the identification of Tyr-227 of hemopexin as a target for (a,b) Nitroubiquitin 50 was added to human plasma and, after tryptic digestion, the peptides were labeled in two samples differentially by reductive dimethylation by using formaldehyde/ sodium cyanoborohydride and D 13 CDO/sodium cyanoborodeuteride, respectively, as reagents. After enrichment, the relative concentrations of the tagged light (blue shading and line) and heavy dimethyl-labeled # TLSDY ∆ NIQK # (red shading and line) reflected nitroubiquitin concentrations accurately both in the XICs (a) and in the narrow-range ESI-FTMS spectrum (b) obtained through averaging over their elution period. We observed no chromatographic isotope effect.
modification 19 , which we could not identify without the use of the enrichment procedure reported in this protocol. Optimization has included the introduction of hardware (screw-cap spin column; Fig. 4 ) that facilitated a thorough washing of the SPAER after the immobilization of the dimethylated 3AT-containing peptides, which minimizes carryover. Anticipated enrichment factors estimating the degree of retaining the specifically modified peptides over the removal of unmodified peptides are, depending on protein abundances and the extent of the targeted PTM, at least several hundred but may exceed ten thousand by the use of chemoprecipitation 24 . A typical result showing relative quantification of a nitroprotein from two human plasma samples is shown in Figure 6 (ref. 33) .
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